Atara Biotherapeutics: Q1 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a first-quarter loss of $4.1 million, after reporting a profit in the same period a year earlier.

The Thousand Oaks, California-based company said it had a loss of 29 cents per share.

The drug developer posted revenue of $516,000 in the period.

Atara Biotherapeutics shares have declined 46% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.81, a climb of 52% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up